×
About 1,353 results

ALLMedicine™ Chronic Gastritis Center

Research & Reviews  456 results

Involvement of Helicobacter pylori in Preoperative Gastric Findings on a Bariatric Popu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332016
International Journal of Environmental Research and Publi... García-Gómez-Heras S, Fernández-Aceñero MJ et. al.

Jul 29th, 2022 - The prevalence of Helicobacter pylori (Hp) in bariatric patients is common and related to gastric pathology. With preoperative upper gastrointestinal endoscopy (UGE), these pathologies and the presence of Hp are diagnosed. The histopathological st...

Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-resident Memor...
https://doi.org/10.1158/2326-6066.CIR-22-0107
Cancer Immunology Research; Peng R, Liu S et. al.

Jul 27th, 2022 - The host microbiota is tightly associated with tumor initiation and progression in multiple solid tumors including gastric cancer (GC). The aim of this study was to investigate in patients with GC whether there are alterations in gastric microbiot...

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
https://clinicaltrials.gov/ct2/show/NCT05152004

Jul 20th, 2022 - Helicobacter pylori (H. pylori) infect more than 50% of humans globally. It is the principal cause of chronic gastritis, gastric ulcer, duodenal ulcer, gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue lymphoma (MALToma). The Re...

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
https://clinicaltrials.gov/ct2/show/NCT05024721

Jul 14th, 2022 - The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.

Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apopto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242521
PLoS Pathogens; Palrasu M, Zaika E et. al.

Jun 30th, 2022 - Helicobacter pylori (H. pylori) is a common gastric pathogen that infects approximately half of the world's population. Infection with H. pylori can lead to diverse pathological conditions, including chronic gastritis, peptic ulcer disease, and ca...

see more →

Guidelines  1 results

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  65 results

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
https://clinicaltrials.gov/ct2/show/NCT05152004

Jul 20th, 2022 - Helicobacter pylori (H. pylori) infect more than 50% of humans globally. It is the principal cause of chronic gastritis, gastric ulcer, duodenal ulcer, gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue lymphoma (MALToma). The Re...

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
https://clinicaltrials.gov/ct2/show/NCT05024721

Jul 14th, 2022 - The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.

The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in Adults
https://clinicaltrials.gov/ct2/show/NCT05399862

Jun 1st, 2022 - The prime discovery of Helicobacter pylori (H. pylori) in chronic gastritis patients by Marshall and Warren in 1982 has geared a frenetic pace in H. pylori research. H. pylori is a helix-shaped microaerophilic gram negative bacterium colonising ga...

Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori
https://clinicaltrials.gov/ct2/show/NCT05191875

May 24th, 2022 - Background: Helicobacter pylori(H.pylori)infection is a common bacterial infection that causes chronic gastritis, peptic ulcer, MALT lymphoma, gastric cancer, and other gastrointestinal diseases. and has been classified as a group 1 biologic carci...

Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT05332444

May 19th, 2022 - This prospective multicenter randomized comparative study will be conducted at the National Taiwan University Hospital, NTUH Bei-Hu Branch, NTUH Hsin-Chu Branch, Taipei City Hospital Renai Branch, Buddhist Tzu Chi General Hospital, and Mennonite C...

see more →

News  16 results

Fast Five Quiz: Helicobacter pylori
https://reference.medscape.com/viewarticle/950663

Jan 20th, 2022 - Helicobacter pylori is a gram-negative microaerophilic bacterium that infects the lining of the stomach. It is the chief cause of chronic gastritis and the primary etiological agent for gastric cancer and peptic ulcer disease (PUD). Despite effort...

Pink plaque on the ear
https://www.mdedge.com/familymedicine/article/237252/dermatology/pink-plaque-ear
MDedge Family Medicine;

Mar 25th, 2021 - A 4-mm punch biopsy was performed and revealed B-cell lymphoma, consistent with extranodal marginal zone lymphoma. The plaque was palpated carefully and the location of branches of the superficial temporal artery, which usually course anterior to.

Chronic Gastritis, a Lesion, and Weight Loss in a Teenager
https://reference.medscape.com/viewarticle/843821

Feb 19th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

H. Pylori Tx Cuts Gastric Cancer Risk Long Term
https://www.medpagetoday.com/gastroenterology/pepticulcerdisease/89849

Nov 23rd, 2020 - Helicobacter pylori (H. pylori) therapy and eradication protected against progression to gastric cancer in Hispanic patients with pre-cancerous lesions, and the protective effect of therapy endured at 20 years, researchers reported. In the longest...

What is your diagnosis? - March 2020
https://www.mdedge.com/gihepnews/article/218065/what-your-diagnosis-march-2020
Diogo Turiani Hourneaux de Moura, MD, MSc, PhD, Kelly E. Hathorn et. al.

Feb 28th, 2020 - Squamous metaplasia Weight regain can accompany re-emergence of obesity-related comorbidities and, thus, early intervention is important. Although diet, exercise, and behavior modifications are fundamental, they can have limited efficacy.

see more →

Patient Education  2 results see all →